Helping an Emerging Manufacturer Gain Top-notch Valuation in a $10B Pharma Acquisition March 3, 2022 INF Second Read
Contracts & Pricing September 4, 2024 Understanding the $35 Patient Out-of-Pocket Strategy: Implications for Pharmaceutical Manufacturers 2 Minute Read